Yu‐Ling Tsai

1.2k total citations
36 papers, 941 citations indexed

About

Yu‐Ling Tsai is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Yu‐Ling Tsai has authored 36 papers receiving a total of 941 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Cancer Research and 8 papers in Immunology. Recurrent topics in Yu‐Ling Tsai's work include Cancer, Lipids, and Metabolism (6 papers), Glioma Diagnosis and Treatment (4 papers) and Cholesterol and Lipid Metabolism (4 papers). Yu‐Ling Tsai is often cited by papers focused on Cancer, Lipids, and Metabolism (6 papers), Glioma Diagnosis and Treatment (4 papers) and Cholesterol and Lipid Metabolism (4 papers). Yu‐Ling Tsai collaborates with scholars based in Taiwan, United States and China. Yu‐Ling Tsai's co-authors include Chih‐Jung Chang, Tsung-Ru Wu, Hsin‐Chih Lai, Chia‐Chen Lu, Tzu-Lung Lin, Wei-Fan Lai, Sheng‐Dun Lin, Kung‐Chi Chan, Kuo‐Feng Hua and Shuk‐Man Ka and has published in prestigious journals such as SHILAP Revista de lepidopterología, The FASEB Journal and Free Radical Biology and Medicine.

In The Last Decade

Yu‐Ling Tsai

33 papers receiving 921 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu‐Ling Tsai Taiwan 15 477 169 158 115 84 36 941
Chu‐Chyn Ou Taiwan 18 486 1.0× 96 0.6× 174 1.1× 79 0.7× 82 1.0× 45 1.1k
Jana Větvičková United States 22 371 0.8× 220 1.3× 141 0.9× 95 0.8× 75 0.9× 55 1.3k
Ying Guo China 20 496 1.0× 86 0.5× 88 0.6× 86 0.7× 103 1.2× 60 1.0k
Natarajan Bhaskaran United States 20 629 1.3× 262 1.6× 88 0.6× 85 0.7× 96 1.1× 42 1.4k
In‐Chul Lee South Korea 21 465 1.0× 173 1.0× 61 0.4× 145 1.3× 91 1.1× 81 1.3k
Jiuxi Liu China 15 530 1.1× 125 0.7× 110 0.7× 65 0.6× 62 0.7× 25 938
Lawrence Owusu China 16 466 1.0× 154 0.9× 70 0.4× 74 0.6× 46 0.5× 26 877
Shuang Luo China 17 443 0.9× 185 1.1× 80 0.5× 80 0.7× 40 0.5× 40 1.0k
Prakash Babu Narasimhan India 15 301 0.6× 282 1.7× 91 0.6× 80 0.7× 50 0.6× 33 1.0k
Jiajia Dong China 17 371 0.8× 104 0.6× 93 0.6× 96 0.8× 60 0.7× 47 918

Countries citing papers authored by Yu‐Ling Tsai

Since Specialization
Citations

This map shows the geographic impact of Yu‐Ling Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Ling Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Ling Tsai more than expected).

Fields of papers citing papers by Yu‐Ling Tsai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Ling Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Ling Tsai. The network helps show where Yu‐Ling Tsai may publish in the future.

Co-authorship network of co-authors of Yu‐Ling Tsai

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Ling Tsai. A scholar is included among the top collaborators of Yu‐Ling Tsai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Ling Tsai. Yu‐Ling Tsai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lin, Yi‐Hsuan, et al.. (2024). GW4064 inhibits migration and invasion through cathepsin B and MMP2 downregulation in human bladder cancer. Chemico-Biological Interactions. 389. 110869–110869. 8 indexed citations
3.
Jin, Jong‐Shiaw, et al.. (2024). Effectively α-Terpineol Suppresses Glioblastoma Aggressive Behavior and Downregulates KDELC2 Expression. Phytomedicine. 127. 155471–155471. 5 indexed citations
4.
Lin, Yi‐Hsuan, et al.. (2024). Pyr3 inhibits cell viability and PKCα activity to suppress migration in human bladder cancer cells. European Journal of Pharmacology. 988. 177235–177235.
5.
Lin, Yi‐Hsuan, et al.. (2024). The Reduction of PSMB4 in T24 and J82 Bladder Cancer Cells Inhibits the Angiogenesis and Migration of Endothelial Cells. International Journal of Molecular Sciences. 25(10). 5559–5559. 2 indexed citations
6.
Liu, Pei‐Yao, Chih‐Yuan Chen, Yu‐Lung Lin, et al.. (2023). RNF128 regulates neutrophil infiltration and myeloperoxidase functions to prevent acute lung injury. Cell Death and Disease. 14(6). 21 indexed citations
7.
Jin, Jong‐Shiaw, Yu‐Ling Tsai, Yu‐Chan Chang, & Wen‐Chiuan Tsai. (2023). Low Expression of A3C and PLP2 Indicating a Favorable Prognosis in Human Gliomas. Cellular and Molecular Biology. 69(7). 71–79. 1 indexed citations
8.
Tsai, Yu‐Ling, et al.. (2023). KDELC2 Upregulates Glioblastoma Angiogenesis via Reactive Oxygen Species Activation and Tumor-Associated Macrophage Proliferation. Antioxidants. 12(4). 923–923. 6 indexed citations
10.
Lin, Chieh‐Hsin, Wen‐Chiuan Tsai, Yu‐Ling Tsai, et al.. (2022). Fatty Acid Binding Protein 6 Inhibition Decreases Cell Cycle Progression, Migration and Autophagy in Bladder Cancers. International Journal of Molecular Sciences. 23(4). 2154–2154. 19 indexed citations
12.
Tsai, Yu‐Ling, et al.. (2022). Enhancement of Farnesoid X Receptor Inhibits Migration, Adhesion and Angiogenesis through Proteasome Degradation and VEGF Reduction in Bladder Cancers. International Journal of Molecular Sciences. 23(9). 5259–5259. 10 indexed citations
13.
Chang, Chih‐Jung, Tzu-Lung Lin, Yu‐Ling Tsai, et al.. (2019). Next generation probiotics in disease amelioration. Journal of Food and Drug Analysis. 27(3). 615–622. 255 indexed citations
14.
Hua, Kuo‐Feng, Yu‐Ling Tsai, Lichieh Julie Chu, et al.. (2019). Compound K inhibits priming and mitochondria-associated activating signals of NLRP3 inflammasome in renal tubulointerstitial lesions. Nephrology Dialysis Transplantation. 35(1). 74–85. 30 indexed citations
15.
Yang, Sung‐Sen, et al.. (2016). SPAK plays a pathogenic role in IgA nephropathy through the activation of NF-κB/MAPKs signaling pathway. Free Radical Biology and Medicine. 99. 214–224. 19 indexed citations
16.
17.
Tsai, Yu‐Ling, Chien‐Chih Chiu, Jeff Yi‐Fu Chen, Kung‐Chi Chan, & Sheng‐Dun Lin. (2012). Cytotoxic effects of Echinacea purpurea flower extracts and cichoric acid on human colon cancer cells through induction of apoptosis. Journal of Ethnopharmacology. 143(3). 914–919. 78 indexed citations
18.
Chu, Pei‐Yu, Po‐Liang Lu, Yu‐Ling Tsai, et al.. (2011). Spatiotemporal phylogenetic analysis and molecular characterization of coxsackievirus A4. Infection Genetics and Evolution. 11(6). 1426–1435. 17 indexed citations
19.
Lee, Ching‐Ching, et al.. (2010). Quality Characteristics of Erythritol Icebox Cookies. 48(2). 64–73. 3 indexed citations
20.
Chu, Pei‐Yu, Yu‐Ling Tsai, Hsiu‐Lin Chen, et al.. (2009). Coxsackievirus B4 in Southern Taiwan: Molecular Epidemiology. Journal of Clinical Virology. 45(1). 16–22. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026